Company & Sponsor Intelligence

Neuroscience Trials Australia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials3
Recruiting0
Completed2
Countries1

Therapeutic footprint

alzheimersstroke

Indexed studies

NCT01846247A Very Early Rehabilitation Trial
stroke · Australia
NA
NCT03234686Deferiprone to Delay Dementia (The 3D Study)
alzheimers · Australia
PHASE2
NCT03287076Trial of EXenatide in Acute Ischaemic Stroke
stroke · Australia
PHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →